GlassScriptPhysician profile
Gary J Merlino
NPI 1760483192
$10,826.51
in general payments reported to CMS, 2019-2025
45 companies · $990 in 2025
The $990 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,707 · 2020: $1,419 · 2021: $1,604 · 2022: $1,681 · 2023: $1,752 · 2024: $1,673 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,414.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,532.10 | 2021-2025 | |
| Allergan, INC. | $1,384.96 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $1,124.18 | 2019-2024 | Xarelto |
| Pfizer INC. | $1,038.13 | 2019-2025 | |
| Novo Nordisk INC | $794.40 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amarin Pharma, INC. | $425.04 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $424.34 | 2019-2024 | Eliquis |
| Abbott Laboratories | $399.31 | 2021-2024 | Gallant, Aveir |
| Lilly USA, LLC | $397.24 | 2020-2025 | Mounjaro, Zepbound |
| Viiv Healthcare Company | $357.54 | 2024-2025 | Apretude |
| Gilead Sciences, INC. | $324.37 | 2023-2024 | Veklury |
| Galderma Laboratories, L.P. | $256.58 | 2020-2024 | |
| Inari Medical, INC. | $239.45 | 2020-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Idorsia Pharmaceuticals US INC | $169.16 | 2023-2024 | Quviviq |
| Saluda Medical Americas, INC. | $153.11 | 2024 | Evoke |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Merlino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.